论文部分内容阅读
根据近期出版的《胸腔》杂志发表的一项研究结果显示,在哮喘青少年和成年患者中,氟替卡松的大部分临床功效可在200mcg/天的剂量基础上获得。绝大多数患者每天用药500或1000mcg 所产生的效果与200mcg相比并无更多益处。来自于惠灵顿的新西兰医学
According to a study published recently in the journal Thorax, most of the clinical efficacy of fluticasone in asthmatic adolescents and adult patients was obtained on a 200-mcg / day basis. The effect of 500 or 1000 mcg administered daily to most patients is no more beneficial than 200 mcg. New Zealand medicine from Wellington